Stockreport

Lipocine Highlights Promising Interim Safety Profile in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD) [Yahoo! Finance]

Lipocine Inc.  (LPCN) 
Last lipocine inc. earnings: 11/12 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.lipocine.com
PDF More than half of planned participants have completed dosing with no dose reductions, discontinuations, drug-related SAEs, loss of consciousness, or excessive sedation [Read more]